Molecular Partners Ag (MOLN) Net Income towards Common Stockholders: 2020-2025
Historic Net Income towards Common Stockholders for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$14,796.
- Molecular Partners Ag's Net Income towards Common Stockholders rose 21.85% to -$14,796 in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.3 million, marking a year-over-year increase of 0.26%. This contributed to the annual value of -$61.4 million for FY2024, which is 10.99% up from last year.
- Latest data reveals that Molecular Partners Ag reported Net Income towards Common Stockholders of -$14,796 as of Q3 2025, which was up 99.94% from -$24.6 million recorded in Q2 2025.
- Molecular Partners Ag's 5-year Net Income towards Common Stockholders high stood at $122.2 million for Q4 2022, and its period low was -$69.8 million during Q4 2023.
- For the 3-year period, Molecular Partners Ag's Net Income towards Common Stockholders averaged around -$17.3 million, with its median value being -$18,934 (2024).
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 1,005.57% in 2022, then plummeted by 378,595.28% in 2023.
- Quarterly analysis of 5 years shows Molecular Partners Ag's Net Income towards Common Stockholders stood at -$13,406 in 2021, then decreased by 2.90% to $122.2 million in 2022, then plummeted by 157.15% to -$69.8 million in 2023, then climbed by 11.73% to -$61.6 million in 2024, then grew by 21.85% to -$14,796 in 2025.
- Its Net Income towards Common Stockholders stands at -$14,796 for Q3 2025, versus -$24.6 million for Q2 2025 and -$18,655 for Q1 2025.